Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caviro Extra is the circular economy division of the Caviro Group, specializing in the recovery and transformation of wine and food industry by-products into high-value ingredients. The company operates a sophisticated bio-refinery that produces pharmaceutical-grade ethanol, natural tartaric acid, and grape seed extracts for the life sciences, pharmaceutical, and cosmetic industries. By utilizing advanced distillation and extraction technologies, Caviro Extra provides sustainable raw materials while minimizing environmental impact. Their portfolio also includes bio-energies and organic fertilizers, positioning them as a key player in the European bio-economy. The company is a major global supplier of natural tartaric acid, which is used as an excipient and active ingredient in various pharmaceutical formulations. Caviro Extra's commitment to sustainability is evidenced by its integrated production cycle that converts waste into renewable energy and bio-based products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caviro Extra.